None
Conditions
Interventions
Remimazolam besylate group:Remimazolam besylate (ED95 from phase I) was used for induction and maintenance.
AI Propofol group(YNMT)· :Patients received induction and maintenance of propofol (body weight standard dose).
Sponsors
Guizhou Aerospace Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.ASA grade I-III; 2.They voluntarily participated and signed informed consent forms.
Exclusion criteria
Exclusion criteria: 1. Allergy to study drugs; 2. Severe liver and kidney dysfunction; 3. Long-term use of sedatives; 4. History of mental illness or cognitive impairment; 5. Emergency surgery.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Successful anesthesia (defined as no obvious choking, breathing, body movement and other reactions during glottis insertion);Success rate of anesthesia;The incidence of delirium within 24 hours after the operation; | — |
Secondary
| Measure | Time frame |
|---|---|
| Induction time;Awakening time;The incidence of adverse events such as intraoperative hypotension/respiratory depression;Patient and operator satisfaction; | — |
Countries
China
Contacts
Public ContactChen Yahua
Guizhou Aerospace Hospital
Outcome results
None listed